Stock & Company Details
Harmony Biosciences Holdings Inc $HRMY
Price:
N/A
N/A
58M
$2.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
12.49
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
HRMY technical indicators
Latest Harmony Biosciences Holdings Inc (HRMY) indicator readings as of 2026-10-29.
HRMY's 14-day RSI is 50.1, in neutral territory. At $38.59 it is trading 11.3% above its 200-day moving average of $34.68, and below its 50-day average of $39.75. Price sits in the middle of its Bollinger Bands ($35.94 to $40.64). ADX reads 27.4, indicating a trending market.
Overview
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Finance Bot
Ask your questions
Start by typing a question below.
